6533b82afe1ef96bd128c376

RESEARCH PRODUCT

[Contraception in chronically ill adolescents].

C Drexel-finkF Peters

subject

Malemedicine.medical_specialtyPediatricsAdolescentAnemiaSexual BehaviorDiseaseThrombophiliaDiabetes mellitusmedicineHumansGlycemicGynecologybusiness.industryContraindicationsObstetrics and Gynecologymedicine.diseasePremature ovarian failureChronic diseaseContraceptionDiabetes Mellitus Type 1Sexual behaviorChronic DiseaseFemalebusinessSexualityContraceptives Oral

description

Contraception in chronically ill adolescents has to consider side effects with regard to metabolic or hematological disease. Additionally the compliance of the patient has to be taken in account when consulting about contraceptives. In juvenile diabetics with good glycemic control and metabolic diseases of the amino acids oral contraceptives are justifiable. Adolescents with galactose-mia mostly suffer from premature ovarian failure and therefore have to be controlled wether they need contraception at all. Young women with sickle-cell anemia are at risk of thrombophilia. They should not be given hormonal contraceptives. In v. Willebrand-Jurgens-Syndrome oral contraceptives are favourable because it alleviates menorrhagia.

yearjournalcountryeditionlanguage
2003-04-25Zentralblatt fur Gynakologie
10.1055/s-2002-38913https://pubmed.ncbi.nlm.nih.gov/12712387